Inosine Pranobex
- Generic Name
- Inosine Pranobex
- Brand Names
- Imunovir
- Drug Type
- Small Molecule
- Chemical Formula
- C52H78N10O17
- CAS Number
- 36703-88-5
- Unique Ingredient Identifier
- W1SO0V223F
- Background
Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.
- Indication
用于单纯性疱疹病毒感染。
- Associated Conditions
- Subacute Sclerosing Panencephalitis
- Associated Therapies
- -
Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 100
- Registration Number
- NCT04360122
- Locations
- 🇪🇬
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt
A Study of Isoprinosine in Patients With Severe AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002295
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002059
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002061
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
A Study of Isoprinosine in Patients With Lymph Node Disease
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002297
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002296
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-08-26
- Target Recruit Count
- 20
- Registration Number
- NCT00000699
- Locations
- 🇺🇸
George Washington Univ Med Ctr, Washington, District of Columbia, United States
A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Newport Pharmaceuticals International
- Registration Number
- NCT00002060
- Locations
- 🇺🇸
Newport Pharmaceuticals International Inc, Laguna Hills, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.